TOCILIZUMAB
Showing 1 - 25 of 633
Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)
Recruiting
- Tocilizumab
- Thyroid Associated Ophthalmopathy
- Tocilizumab
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Oct 11, 2023
Giant Cell Arteritis Trial in Dijon (drug, other, biological, procedure)
Not yet recruiting
- Giant Cell Arteritis
- Tocilizumab treatment
- +3 more
-
Dijon, FranceChu Dijon Bourgogne
Sep 7, 2023
Retroperitoneal Fibrosis, Tocilizumab Treatment Trial in Beijing (Tocilizumab treatment, Prednisone Monotherapy)
Recruiting
- Chronic Periaortitis
- Tocilizumab Monotherapy
- Tocilizumab monotherapy
-
Beijing, ChinaYunyun Fei
Oct 22, 2022
Malignant Pleural Effusion, Malignant Ascites Trial in Pittsburgh (Tocilizumab)
Not yet recruiting
- Malignant Pleural Effusion
- Malignant Ascites
- Tocilizumab
-
Pittsburgh, PennsylvaniaAllegheny Health Network Cancer Institute
Aug 30, 2023
Aneurysm, Behcet Syndrome, Vascular Type Trial in Beijing (tocilizumab, tofacitinib, cyclophosphamide)
Not yet recruiting
- Aneurysm
- Behcet Syndrome, Vascular Type
- tocilizumab
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 26, 2023
Sickle Cell Disease, Acute Chest Syndrome Trial (Tocilizumab)
Not yet recruiting
- Sickle Cell Disease
- Acute Chest Syndrome
- Tocilizumab
- (no location specified)
Nov 28, 2022
Multiple Myeloma Trial in Suzhou (Tocilizumab)
Recruiting
- Multiple Myeloma
- Tocilizumab
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
May 3, 2023
A Time to Cardiovascular Event Analysis Comparing Tocilizumab to
Completed
- Rheumatoid Arthritis
- Other Biologics
- Tocilizumab
- (no location specified)
Jan 20, 2023
Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)
Active, not recruiting
- Hematologic Malignancy
- Tacrolimus
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital
Jan 31, 2023
Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Carboplatin
- Tocilizumab
-
Carmel, Indiana
- +2 more
Apr 27, 2023
Tocilizumab Versus Tocilizumab/Infliximab in COVID-19-associated
Completed
- Covid19
- +2 more
- Tocilizumab
- Infliximab
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Tocilizumab
-
Nantes, FranceCHU of Nantes
Dec 16, 2022
Breast Cancer Trial in Fayoum (Tocilizumab, traditional Covid -19 therapy)
Completed
- Breast Cancer
- Tocilizumab
- traditional Covid -19 therapy
-
Fayoum, EgyptALsafwa specialized hospital
Oct 31, 2022
COVID-19 Trial in Chicago (Tocilizumab, Standard of Care)
Recruiting
- COVID-19
- Tocilizumab
- Standard of Care
-
Chicago, IllinoisUniversity of Chicago Medicine
May 11, 2022
COVID-19 Trial in Chicago (Tocilizumab)
Completed
- COVID-19
- Tocilizumab
-
Chicago, IllinoisUniversity of Chicago Medicine
May 13, 2022
Esophageal Adenocarcinoma, Oesophageal Adenocarcinoma, Resectable Carcinoma Trial in Amsterdam (Tocilizumab 20 Mg/mL Intravenous
Active, not recruiting
- Esophageal Adenocarcinoma
- +2 more
- Tocilizumab 20 Mg/mL Intravenous Solution
- +3 more
-
Amsterdam, NetherlandsAcademic Medical Center, Medical Oncology
Dec 15, 2022
Myasthenia Gravis, Generalized Trial in China (Tocilizumab Injection)
Enrolling by invitation
- Myasthenia Gravis, Generalized
- Tocilizumab Injection
-
Beijing, Beijing, China
- +5 more
Jan 27, 2023
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Tocilizumab
- Venetoclax
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jan 24, 2023
Juvenile Idiopathic Arthritis Trial (Upadacitinib, Tocilizumab)
Not yet recruiting
- Juvenile Idiopathic Arthritis
- Upadacitinib
- Tocilizumab
- (no location specified)
Nov 7, 2022
Coronary Artery Disease, Aortic Valve Disease Trial in Copenhagen (Tocilizumab, Isotonic sodium chloride (0.9%), Dexamethasone
Recruiting
- Coronary Artery Disease
- Aortic Valve Disease
- Tocilizumab
- +8 more
-
Copenhagen, DenmarkThe Heart Centre, Rigshospitalet
Nov 29, 2022
Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA
Active, not recruiting
- GCA
- +3 more
- Tocilizumab 162Mg/0.9Ml Autoinjector
-
Reggio Emilia, Emilia Romagna, ItalyAusl-Irccs - S.C. Di Reumatologia
May 26, 2022
Lung Transplant Trial in Canada, United States (Tocilizumab, Placebo for Tocilizumab)
Not yet recruiting
- Lung Transplant
- Tocilizumab
- Placebo for Tocilizumab
-
Phoenix, Arizona
- +16 more
Sep 8, 2023
Tocilizumab in Covid-19 Penumonia in Buenos Aires City
Completed
- COVID-19 Pneumonia
- Tocilizumab
-
Buenos Aires, ArgentinaNazareno Galvalisi
May 16, 2022
COVID-19 Trial in Patras (Tocilizumab, Baricitinib)
Recruiting
- COVID-19
- Tocilizumab
- Baricitinib
-
Patras, GreeceUniversity Hospital of Patras, Department of Respiratory Medicin
Apr 5, 2022